NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Preterm LaborPreterm Birth

Interventions

DEVICE

PAMG-1 immunoassay

The procedure includes the insertion of a PAMG-1 swab into the subject's vaginal vault without a speculum for one minute. Once the swab is obtained, the treating physician will place the swab in a solvent vial for one minute. A developing strip is then placed in a vial and allowed to develop for five minutes. The results are read from the developing strip.

Trial Locations (1)

52242

University of Iowa, Iowa City